Mohammad AskarPublic working copy · medical review pending

Anophthalmic socket · 194

The anophthalmic socket: choose surgery and restore comfort

Establish the cause and tumour risk before selecting evisceration, enucleation or exenteration.

Public working copy · medical review pending. Source, translation and medical checks remain open. Read the limitations in the text and references. These educational materials do not replace individual medical assessment. Published: 2026-11-18T19:45:52+01:00. Internal project references lead to this notice. They are not publicly accessible primary sources; the source limitations remain stated in the text.

Plan disease control, volume, fornices and prosthetic support together; postoperative symptoms need a cause-directed examination.

Terminology and draft status

Terminology review is not complete. No new WHO UMD entry verification is claimed; pending entries and limits are recorded in terminology.md.

01Clarify the indication and verify the side

The goals are relief of pain in a blind eye, appropriate tumour or infection control, tissue diagnosis when indicated, and a comfortable stable socket for a prosthesis. Fornix depth, orbital volume, closure and mobility all matter; a cosmetic result alone does not define success. 1

Review the cause, previous surgery, visual potential and oncology history; verify the correct eye with the patient, records, marking and team time-out. When the fundus is obscured, B-scan and selected further imaging help assess hidden disease, but a negative scan does not guarantee absence of malignancy. Suspected tumour changes the operation plan before the globe is opened. 1 2 3

A multicentre retrospective clinicopathological series found unsuspected uveal melanoma in 7 eviscerated blind painful eyes: imaging had not been obtained in 3 and had missed tumour in 4. This selected case series has no denominator for estimating incidence. Necrosis-related inflammation can mimic infection; persistent suspicion requires specialist assessment and histopathology. 2

A newer UK retrospective pathology study began with 1897 specimens from 2014–2023; 664 met its inclusion criteria and 5 contained unsuspected malignancy (0.75%), all after evisceration, including one corneal-button malignancy. Preoperative assessment had not identified these lesions. Selection and retrospective records limit generalisation; 0.75% is not the risk for every blind eye or every ultrasound examination. 3

02Match tissue removal to the disease

Evisceration removes the intraocular contents while retaining the scleral shell and extraocular muscle attachments; the original describes peritomy, corneal removal and an evisceration spoon, with an implant in or behind the sclera according to technique. Reduced dissection and mobility are potential advantages, not guarantees. Known or suspected intraocular malignancy contraindicates this approach because opening and retaining the scleral shell may leave or disseminate tumour. 1 2 3

Enucleation removes the entire globe after detaching the extraocular muscles and dividing the optic nerve. It may be appropriate for selected uveal melanoma or retinoblastoma and for other eyes requiring removal; many tumours have other treatment options. Plan with ocular oncology and obtain proper pathological assessment, including the optic-nerve cut margin when relevant. 1

The retinoblastoma teaching goal of about 10–12 mm of optic nerve is not a universally achievable safe length or a guarantee against CNS spread. Avoid globe rupture and excessive traction; anatomy, tumour extent, margin assessment and the oncology plan matter more than forcing a memorised measurement. An implant introducer or plunger is a technique-dependent aid, not a compulsory instrument. 1

Exenteration removes orbital tissue to an extent planned for the lesion: subtotal, total, lid-sparing or extended to involved bone or sinus. It is not the automatic operation for every extraocular extension. Multidisciplinary reconstruction may use a temporalis flap through a tailored route or a free radial-forearm flap; tissue extent, wound bed and rehabilitation determine the choice. 1

03Discuss sympathetic ophthalmia without a prevention guarantee

Sympathetic ophthalmia (SO) is a rare bilateral inflammatory disease after ocular trauma or surgery. The original 0.03/100000 figure lacks a verified procedure-specific denominator and follow-up and must not be quoted as an established evisceration risk. Neither retained uveal tissue alone nor eye removal alone establishes an individual outcome. New symptoms in the fellow eye require prompt examination. 1

The available meta-analysis did not find evidence that primary enucleation or evisceration after open-globe injury reduces subsequent SO. The accessed conclusion does not establish equivalence or zero risk, and the full study appraisal remains incomplete. Prophylactic removal of an eye with visual potential cannot be justified simply by promising protection of the other eye. 4

The meta-analysis combined 8 observational studies with 7620 included open-globe injuries and 21 SO cases. Among 779 patients with primary removal no cases were reported, yet the modelled rate was 0.05% (95% CI 0.00–0.21%), versus 0.15% (0.00–0.33%) after repair. The reported modelled risk difference was −0.0010 (95% CI −0.0031 to 0.0011). Low certainty, missing data and confounding limit causal inference; the interval includes benefit in either direction. 4

04Choose the implant and manage the wound bed

Separate appropriate deep layers and conjunctiva with viable tissue and limited tension. Multilayer closure reduces some mechanical problems but cannot guarantee no exposure or extrusion. Coordinate anaesthetic monitoring during muscle manipulation because an oculocardiac reflex can cause clinically important bradycardia. 1

Nonporous silicone, PMMA or glass and porous hydroxyapatite or polyethylene differ in handling and integration. Porous implants allow fibrovascular ingrowth; muscle fixation and coverage depend on design. Infection, exposure and migration depend on tissue quality, technique, implant and patient factors, so there is no universal porous-versus-nonporous complication ranking. 1

An autologous dermis-fat graft (DFG), often harvested from abdomen or buttock, is one option for primary or secondary volume replacement, including selected children. Growth, overgrowth, atrophy and graft survival vary. The original claim that every graft loses about 50% and must be oversized is not established; oversizing can itself create pressure and closure problems. 1 5

A retrospective series of 16 children aged 2 months–17 years had 2–15 years of follow-up. 6 of 8 implanted at age ≤4 years needed debulking for increasing proptosis; none of 8 aged ≥9 years needed it, and 5 older children showed some atrophy. The small historical series illustrates variable growth, not universal age cutoffs or a standard oversizing percentage. 5

05Find the cause of discharge, exposure or asymmetry

A deep superior sulcus suggests volume or support imbalance. Assess orbital implant position, prosthesis fit and lid support before selected hyaluronic filler, fat transfer or a subperiosteal/wedge implant. These are different procedures with their own risks, not interchangeable routine remedies. 1

Mucus retention in an excessively deep fornix may contribute to chronic discharge, described in the original as giant fornix syndrome. Check prosthesis fit, infection, surface irritation and implant exposure before steroids or selected fornix reduction. Conjunctival cysts or an unexplained new nodule require direct examination; steroid treatment must not hide infection or a mass. 1

Distinguish exposure, in which covering tissue breaks down, from extrusion or displacement of the implant. Assess defect size, infection, vascularity, tension and contributing smoking or wound-healing problems. A patch, revision, implant removal/replacement or DFG may be chosen; the original small-patch/large-DFG rule is not sufficient for every case. 1

For socket ptosis, optimise volume and prosthesis fit before choosing a levator procedure. A Fasanella–Servat approach removes posterior-lamellar tissue and may shorten a vulnerable fornix, so suitability needs individual assessment rather than a universal ban. Spectacle plus/minus lenses can change apparent size; prisms do not physically reposition the prosthesis. Cosmetic optical choices need an ocularist/optical assessment. 1

06Plan rehabilitation and lifelong review

When infection cannot be controlled in a blind painful eye, eye-removal surgery may be considered by the treating team after assessing the cause, extent and occult tumour risk. Evisceration is not an automatic response to every endophthalmitis. Perioperative intravenous or topical antibiotic choices require the actual local protocol and microbiological context, not an unverified generic S1 label. 1

A conformer maintains the socket space and fornices while healing when appropriate. Definitive prosthesis fitting often waits until swelling and wound healing permit it; the original 6–8 weeks is an approximate teaching interval, not a fixed deadline. Coordinate comfort, hygiene, fit and emotional rehabilitation with the ocularist and treating team. 1

The original cleaning once monthly, polishing once yearly and annual ophthalmic examination are examples, not sufficient schedules for every material or patient. Agree individual cleaning and professional maintenance; do not repeatedly remove or manipulate the prosthesis without advice. New discharge, pressure points, pain, fit change, cyst or exposure warrants earlier review. 1

Plan rehabilitation and lifelong review
Procedure / topicClinical conceptSelection principleOriginal numbers / limitsSpecial point
EviscerationRetain sclera and muscle attachmentsExclude suspected malignancy; negative B-scan is not a guarantee0.03/100000 SO is unverifiedSelected spoon/implant technique.
EnucleationRemove the whole globeSelected oncological or other indicationsRB 10–12 mm optic nerve is not a universal safe lengthAvoid rupture/seeding; assess cut margin.
ExenterationRemove planned orbital tissuesExtent and multidisciplinary assessment guide selectionNot automatic for every extraocular lesionSelected temporalis/radial-forearm reconstruction.
Dermis-fat graftAutologous volume replacementAn option in selected children and adultsNo universal 50% atrophy/oversizing ruleAbdominal/buttock donor; growth can be excessive.
ImplantsPorous versus nonporous materialsAssess integration, coverage and wound bedNo universal exposure-risk hierarchyIntroducer/plunger and fixation depend on design.
Lid/optical correctionSymmetry, closure, volume and prosthesis fitSelect levator/other repair after socket assessmentFasanella–Servat is not universally bannedPrisms do not physically move the prosthesis; lenses change apparent size.
AftercareLifelong individual maintenanceAgree hygiene, polishing and clinical follow-upMonthly cleaning/yearly polish/yearly exam are examplesCheck cysts, pressure injury, discharge and exposure earlier when symptomatic.
What are the main learning points?

Plan disease control, volume, fornices and prosthetic support together; postoperative symptoms need a cause-directed examination.

When is assessment urgent?

Severe pain, fever, spreading redness, wound breakdown, implant exposure or a new mass requires prompt assessment. New visual symptoms in the fellow eye after trauma or surgery need urgent ophthalmic review.

References and access status

  1. 1
    Immutable original export; own full anophthalmic-socket export

    Complete export read; original attribution and any recording/transcript or appointment not independently verified.

  2. 2
    Eagle et al. Inadvertent evisceration of eyes containing uveal melanoma (2009); PMID 19204229

    Indexed complete abstract and selected main-text case/discussion excerpts read 17 November 2026. Full case table and actual images not assessed.

  3. 3
    Islam et al. The prevalence of unsuspected intraocular malignancy following eye removal (2026)

    Complete indexed primary abstract read 17 November 2026; full methods, cohort selection details, tables and figures not read.

  4. 4
    Patterson et al. SO and open-globe management meta-analysis (2024); PMID 38086434

    Full primary abstract retrieved through EuropePMC and read 17 November 2026 after an initial sandbox timeout; direct PubMed opening was empty. Main report, study-level tables and full bias appraisal unread.

  5. 5
    Heher et al. Unilateral dermis-fat graft implantation in the pediatric orbit (1998); PMID 9558663

    Complete primary PubMed abstract read 17 November 2026; full historical report, methods and figures not read. Retrospective 16 patient series.